Related Experiment Videos
Treatment of uncomplicated gonorrhea with Polycillin-PRB
Abstract:
Penicillin has remained the choice drug for the treatment of gonorrhea. Its cure rate has been relative, and because cure rates are not as good as one would wish, an additional increase in dosage has been advised. Despite an improved cure rate with increased dosages, we are rapidly approaching a dose requirement beyond that which can be administered practically on an outpatient basis. Therefore other antimicrobial agents have been evaluated for the treatment of gonorrhea. Ampicillin 2 gm (IM) with 1 gm probenecid was evaluated in 1969 with a 99% plus cure rate. It also has been found that 3.5 gm of ampicillin orally (7 capsules of 500 mg) and probenecid (2 tablets of 500 mg) is an effective treatment for gonorrhea. We undertook the present study to evaluate the efficacy of a new single oral combination treatment, Polycillin-PRB.
Insights
Penicillin
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Penicillin is the standard treatment for gonorrhea, but its effectiveness is declining.
- Increasing penicillin dosages is limited by practical outpatient administration constraints.
- Alternative antimicrobial agents are needed for gonorrhea treatment.
Purpose of the Study:
- To evaluate the efficacy of a novel single oral combination treatment for gonorrhea.
- To assess the effectiveness of Polycillin-PRB in treating gonorrhea.
Main Methods:
- Previous studies evaluated ampicillin (2 gm IM) with probenecid (1 gm) in 1969.
- A regimen of 3.5 gm oral ampicillin with probenecid demonstrated effectiveness.
- This study focuses on a new oral combination: Polycillin-PRB.
Main Results:
- Ampicillin (2 gm IM) plus probenecid achieved over 99% cure rate in 1969.
- 3.5 gm oral ampicillin with probenecid is an effective gonorrhea treatment.
- The efficacy of Polycillin-PRB as a single oral treatment is under investigation.
Conclusions:
- Rising resistance necessitates exploring alternative gonorrhea treatments.
- Ampicillin in combination with probenecid shows high cure rates.
- Polycillin-PRB offers a potential new oral therapeutic option for gonorrhea.